ezogabine has been researched along with linopirdine in 29 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (linopirdine) | Trials (linopirdine) | Recent Studies (post-2010) (linopirdine) |
---|---|---|---|---|---|
383 | 26 | 241 | 169 | 8 | 44 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (65.52) | 29.6817 |
2010's | 9 (31.03) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Jegla, T; Wagoner, PK; Wickenden, AD; Yu, W; Zou, A | 1 |
Jegla, T; Wagoner, PK; Wickenden, AD; Zou, A | 1 |
Abogadie, FC; Brown, DA; Delmas, P; Tatulian, L | 1 |
Christensen, JK; Christophersen, P; Dupuis, DS; Jensen, BS; Jespersen, T; Olesen, SP; Schrøder, RL | 1 |
Crankshaw, DJ; Scott, CW; Trivedi, S; Wilkins, DE | 1 |
Al-Qatari, M; Brown, DA; Brown, TA; Burbidge, SA; Dickenson, AH; Main, M; Marsh, SJ; Matthews, EA; Mistry, M; Passmore, GM; Selyanko, AA | 1 |
Hoffmann, EK; Hougaard, C; Jorgensen, NK; Klaerke, DA; Olesen, SP | 1 |
Dost, R; Rostock, A; Rundfeldt, C | 1 |
Yaari, Y; Yue, C | 1 |
Frankel, WN; Otto, JF; White, HS; Wilcox, KS; Yang, Y | 1 |
Jan, LY; Surti, TS | 1 |
Brown, JT; Piccinin, S; Randall, AD | 1 |
Churchill, JF; Lawrence, JJ; McBain, CJ; Saraga, F; Skinner, FK; Statland, JM; Travis, KE | 1 |
Hu, H; Storm, JF; Vervaeke, K | 1 |
Calloe, K; Elmedyb, P; Grunnet, M; Hansen, RS; Olesen, SP; Schmitt, N | 1 |
Greenwood, IA; Moffatt, JD; Ohya, S; Pucovský, V; Saldanha, L; Schwake, M; Yeung, SY | 1 |
Johnson, BN; Qiu, C; Tallent, MK | 1 |
Cherubini, E; Safiulina, VF; Taglialatela, M; Yaari, Y; Zacchi, P | 1 |
Greenwood, IA; Jepps, TA; Moffatt, JD; Ohya, S; Sanders, KM | 1 |
Baraban, SC; Chege, SW; Hortopan, GA; T Dinday, M | 1 |
Cavaliere, S; Hodge, JJ | 1 |
Hughes, BA; Pattnaik, BR | 1 |
King, AE; Visockis, V | 1 |
Hill, MA; Lee, S; Li, M; Tanner, MA; Yang, Y | 1 |
Abidi, A; Aniksztejn, L; Becq, H; Devaux, J; Lacoste, C; Milh, M; Molinari, F; Roubertie, A; Villard, L | 1 |
Byron, KL; Majetschak, M; Nassoiy, SP | 1 |
Greene, DL; Hoshi, N; Kang, S | 1 |
Ambrosino, P; Manocchio, L; Miceli, F; Mosca, I; Soldovieri, MV; Taglialatela, M | 1 |
Li, T; Shen, H; Wang, Y; Wu, K; Yue, Z; Zhang, F | 1 |
2 review(s) available for ezogabine and linopirdine
Article | Year |
---|---|
A potassium channel, the M-channel, as a therapeutic target.
Topics: Animals; Carbamates; Central Nervous System Agents; Clinical Trials as Topic; Humans; Indoles; Molecular Structure; Phenylenediamines; Potassium Channels, Voltage-Gated; Pyridines | 2005 |
Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites.
Topics: Animals; Carbamates; Epilepsy; Humans; Indoles; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Membrane Transport Modulators; Neurons; Phenylenediamines; Potassium Channel Blockers; Pyridines | 2018 |
27 other study(ies) available for ezogabine and linopirdine
Article | Year |
---|---|
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
Topics: Animals; Anticonvulsants; Barium; Carbamates; Cell Differentiation; Cell Line; CHO Cells; Cricetinae; Drug Interactions; Electrophysiology; Humans; Indoles; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; PC12 Cells; Phenylenediamines; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Transfection | 2000 |
Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.
Topics: Animals; Anticonvulsants; Barium; Carbamates; CHO Cells; Cricetinae; Electrophysiology; Indoles; KCNQ3 Potassium Channel; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Plasmids; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Xenopus laevis | 2001 |
Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamates; Cells, Cultured; CHO Cells; Cricetinae; Humans; Indoles; Ion Transport; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Muscarinic Agonists; Neurons; Patch-Clamp Techniques; Phenylenediamines; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Superior Cervical Ganglion; Sympathetic Nervous System; Transfection | 2001 |
Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
Topics: Anthracenes; Carbamates; Cell Line; Dose-Response Relationship, Drug; Gene Expression; Humans; Indoles; KCNQ Potassium Channels; Membrane Potentials; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines | 2002 |
A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.
Topics: Anthracenes; Carbamates; Cell Line; Clone Cells; Dose-Response Relationship, Drug; Humans; Indoles; KCNQ2 Potassium Channel; Kinetics; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Pyridines; Quaternary Ammonium Compounds; Rubidium; Spectrophotometry, Atomic; Tetraethylammonium; Transfection | 2003 |
KCNQ/M currents in sensory neurons: significance for pain therapy.
Topics: Animals; Anthracenes; Anura; Carbamates; Cells, Cultured; CHO Cells; Cricetinae; Disease Models, Animal; Ganglia, Spinal; Hyperalgesia; Indoles; Male; Neurons, Afferent; Oocytes; Pain; Pain Management; Pain Measurement; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transfection | 2003 |
Modulation of KCNQ4 channel activity by changes in cell volume.
Topics: Calcium; Carbamates; Cell Line; Cell Size; Cyclic AMP-Dependent Protein Kinases; Humans; Indoles; KCNQ Potassium Channels; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Osmolar Concentration; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Kinase C; Pyridines; Signal Transduction | 2004 |
The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Topics: Acute Disease; Amines; Analgesics, Opioid; Animals; Carbamates; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Indoles; Ion Channel Gating; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Peripheral Nervous System Diseases; Phenylenediamines; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Wistar; Spinal Nerves; Touch; Tramadol | 2004 |
KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons.
Topics: Action Potentials; Animals; Anthracenes; Carbamates; Hippocampus; In Vitro Techniques; Indoles; Neurons; Phenylenediamines; Potassium; Potassium Channel Blockers; Potassium Channels; Pyramidal Cells; Pyridines; Rats | 2004 |
Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
Topics: Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Electroshock; Female; Genetic Predisposition to Disease; Indoles; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Mutation; Nerve Tissue Proteins; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyridines; Receptors, Nicotinic; Seizures; Sequence Deletion | 2004 |
KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission.
Topics: Action Potentials; Animals; Anthracenes; Calcium; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Hippocampus; In Vitro Techniques; Indoles; KCNQ Potassium Channels; Male; Neurons; Periodicity; Phenylenediamines; Potassium; Potassium Channel Blockers; Pyridines; Rats; Synaptic Transmission | 2006 |
Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons.
Topics: Action Potentials; Animals; Anthracenes; Carbamates; Cell Line; Computer Simulation; Dendrites; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Green Fluorescent Proteins; Hippocampus; Humans; Immunohistochemistry; In Vitro Techniques; Indoles; Interneurons; KCNQ Potassium Channels; Membrane Potentials; Mice; Mice, Transgenic; Models, Neurological; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Pyridines; Tetraethylammonium; Transfection | 2006 |
M-channels (Kv7/KCNQ channels) that regulate synaptic integration, excitability, and spike pattern of CA1 pyramidal cells are located in the perisomatic region.
Topics: Action Potentials; Animals; Anthracenes; Calcium; Carbamates; Cerebral Cortex; Computer Simulation; Dendrites; Electrophysiology; Excitatory Postsynaptic Potentials; Extracellular Space; In Vitro Techniques; Indoles; KCNQ Potassium Channels; Male; Models, Neurological; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Pyramidal Cells; Pyridines; Rats; Rats, Wistar; Synapses; Tissue Distribution | 2007 |
Modulation of ERG channels by XE991.
Topics: Acetylcholine; Animals; Anthracenes; Carbamates; Cell Line; Chromans; Dose-Response Relationship, Drug; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gene Expression; Indoles; Oocytes; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Xenopus laevis | 2007 |
Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.
Topics: Aminopyridines; Animals; Anthracenes; Carbamates; Dose-Response Relationship, Drug; Gene Expression Profiling; Immunohistochemistry; Indoles; Isometric Contraction; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Meclofenamic Acid; Mice; Mice, Inbred BALB C; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylenediamines; Potassium Channel Blockers; Potassium Channels; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2007 |
K+ M-current regulates the transition to seizures in immature and adult hippocampus.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamates; Disease Models, Animal; Epilepsy, Benign Neonatal; Hippocampus; Humans; Indoles; Male; Mutation; Phenylenediamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures | 2007 |
Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus.
Topics: Action Potentials; Animals; Animals, Newborn; Carbamates; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Indoles; KCNQ2 Potassium Channel; Kinetics; Nerve Net; Phenylenediamines; Potassium Channel Blockers; Pyramidal Cells; Pyridines; Rats; Rats, Wistar; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Synaptic Transmission | 2008 |
Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.
Topics: Animals; Anthracenes; Blotting, Western; Carbamates; Chromans; Colon; Gastrointestinal Tract; Immunohistochemistry; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; Myography; Phenylenediamines; Potassium Channel Blockers; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides | 2009 |
Expression and function of KCNQ channels in larval zebrafish.
Topics: Action Potentials; Analysis of Variance; Animals; Anthracenes; Anticonvulsants; Brain; Carbamates; Dose-Response Relationship, Drug; Electrophysiology; Gene Expression Regulation, Developmental; Indoles; KCNQ Potassium Channels; Larva; Locomotion; Morpholinos; Phenylenediamines; Potassium Channel Blockers; Pyridines; RNA, Messenger; Swimming; Zebrafish | 2012 |
Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels.
Topics: Animals; Anthracenes; Carbamates; Cell Line; Chromans; Drosophila; Drosophila Proteins; Electrophysiology; Humans; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Organometallic Compounds; Patch-Clamp Techniques; Phenylenediamines; Pyridines; Sulfonamides | 2011 |
Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Topics: Animals; Carbamates; Cells, Cultured; Chromans; Ethylmaleimide; Indoles; KCNQ Potassium Channels; Macaca fascicularis; Macaca mulatta; Neurons; Organometallic Compounds; Patch-Clamp Techniques; Phenylenediamines; Potassium; Potassium Channel Blockers; Protein Subunits; Pyridines; Retinal Pigment Epithelium; Sulfonamides; Tetraethylammonium | 2012 |
M-channels modulate network excitatory activity induced by 4-aminopyridine in immature rat substantia gelatinosa in vitro.
Topics: 4-Aminopyridine; Action Potentials; Aminopyridines; Analgesics; Animals; Animals, Newborn; Anthracenes; Biological Clocks; Biophysical Phenomena; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Female; In Vitro Techniques; Indoles; Male; Membrane Transport Modulators; Nerve Net; Neurons; Phenylenediamines; Potassium Channel Blockers; Pyridines; Rats; Rats, Wistar; Substantia Gelatinosa | 2013 |
Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.
Topics: Animals; Basilar Artery; Carbamates; Cerebrovascular Circulation; Circle of Willis; Colforsin; Coronary Circulation; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Mice; Mice, Knockout; Muscle Contraction; Muscle, Smooth, Vascular; Organ Specificity; Phenylenediamines; Potassium Channel Blockers; Pyridines; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7/M channel activity.
Topics: Animals; Ankyrins; Anticonvulsants; Carbamates; CHO Cells; Cricetulus; Electric Stimulation; Female; Hippocampus; Humans; Indoles; KCNQ2 Potassium Channel; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Phenylenediamines; Polymorphism, Single Nucleotide; Potassium Channel Blockers; Pyridines; Spasms, Infantile | 2016 |
Kv7 voltage-activated potassium channel inhibitors reduce fluid resuscitation requirements after hemorrhagic shock in rats.
Topics: Animals; Carbamates; Indoles; KCNQ Potassium Channels; Male; Phenylenediamines; Potassium Channel Blockers; Pyridines; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic | 2017 |
XE991 and Linopirdine Are State-Dependent Inhibitors for Kv7/KCNQ Channels that Favor Activated Single Subunits.
Topics: Animals; Anthracenes; Carbamates; CHO Cells; Cricetinae; Cricetulus; Indoles; KCNQ1 Potassium Channel; KCNQ2 Potassium Channel; Kinetics; Membrane Potentials; Mutation; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Protein Subunits; Pyridines; Rats | 2017 |
Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.
Topics: Animals; Carbamates; Cryoelectron Microscopy; Humans; Indoles; KCNQ Potassium Channels; Mutation; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Protein Domains; Pyridines; Sf9 Cells; Spodoptera | 2021 |